Advances in Apoptosis Research (Technical Insights)


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service provides the latest trends in apoptosis research and future developments

Table of Contents

Advances in Apoptosis Research (Technical Insights), Executive SummaryScope and MethodologyScope of the Research ServiceResearch MethodologyInsights into ApoptosisApoptosis and its Relevance in Therapeutics IndustryKey Industry Trends in ApoptosisAdvances in Apoptosis Research (Technical Insights), Technical Focus on Apoptosis PhenomenonApoptosis Molecular Pathways ExplorationKey Categories of Molecular Pathway ProteinsUnderstanding the Role of Apoptosis ProteinsApoptosis Correlated Therapeutic fieldsApoptosis Functioning in Cancer TreatmentApoptosis Basis Connected with Neurodegenerative and Cardiovascular DiseasesOther Cell Apoptosis-Centered DisordersOrgan Transplantation-Associated SyndromesHIV and Cell Sepsis Controlled by ApoptosisApoptosis Identification TechniquesDiagnosis and Analyzing Apoptosis In VivoPotential Markers for Apoptosis RecognitionAdvances in Apoptosis Research (Technical Insights), Assessment of Notable Technologies Involved in Drug Discovery for Apoptosis-Based TreatmentHighlights of Key Developments in the North American region.Triggering Apoptosis:Innovative Oncology Drug Discovery Platform Broad Range of Clinical Development Compounds for the Treatment of Advanced Solid TumorsPromising Small Molecule Investigational Drugs Targeting MalignanciesNovel Cancer Therapies Targeting Treatment Resistance in Oncology PatientsTumor-Targeting Antibodies Delivering Potent Cell-Killing AgentsCell Cycle Inhibitors Work on Cancer through ApoptosisMedical Device Employs Apoptosis to Reduce Cardiac InflammationBCL-2 Emerges as a Hot Target for Cancer TherapeuticsNotable Developments in the Rest of the WorldUnique Anticancer Therapeutics Targeting Cell Death PathwaysNovel Small Molecules Product Targeting Established Tumor Blood VesselsPotential Treatment Paradigm Designed for the Treatment of Solid TumorsPioneering Oligonucleotide-Based Drugs Targeting Malignant TumorsPromising Drug Development Platform with Broad Oncology ApplicationsAdvancements in Progressive Functional Pathways Studies Critical to Cancer Cells GrowthNovel Class of Clinical-Stage Tumor Growth-Reducing Cancer TherapeuticsNovel Drug Therapy for Treating Solid Tumors and Blood CancerHighly Targeted and Potent Antiangiogenic Cancer TherapyUniversities AdvancementsMiniature Stage Biomarker-Focused Translational ResearchNovel Research Findings Identifying Combination Therapy for CancerInnovative Research Findings Exploiting Oncolytic Virus Therapy for Cancer TreatmentAdvances in Apoptosis Research (Technical Insights), Technology Adoption Factor AnalysisDrivers and Challenges Involved in Apoptosis TreatmentNotable DriversChallenges and Restraints Patent Assessment and Analyst InsightsPatent AssessmentAnalyst's Perspective and Futuristic TrendsEntry and Expansion StrategiesAdvances in Apoptosis Research (Technical Insights), Patent Study and Database of Key Participants.Patents ReviewCorporate PatentsAcademic PatentsMain ParticipantsCompaniesUniversitiesAdvances in Apoptosis Research (Technical Insights), Decision Support DatabaseDatabase TablesWorld R&D ExpenditureWorld Healthcare Expenditure (2002 to 2012)Mortality of Bladder Cancer--World (2002 to 2012)Incidence of Bladder Cancer--World (2002 to 2012)Number of Active Physicians (2002 to 2012)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.